載入...
A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma
Locally advanced or metastatic urothelial cancer is an aggressive form of cancer with high recurrence rates and low survival. Nectin-4 is a cell adhesion molecule commonly expressed in several tumors, including high expression in urothelial cancer. Enfortumab vedotin is an antibody–drug conjugate co...
Na minha lista:
| 發表在: | Invest New Drugs |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer US
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7340645/ https://ncbi.nlm.nih.gov/pubmed/31444589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-019-00844-x |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|